The desire for shared decision making among patients with solid and hematological cancer
Article first published online: 17 MAR 2010
Copyright © 2010 John Wiley & Sons, Ltd.
Volume 20, Issue 2, pages 186–193, February 2011
How to Cite
Ernst, J., Kuhnt, S., Schwarzer, A., Aldaoud, A., Niederwieser, D., Mantovani-Löffler, L., Kuchenbecker, D. and Schröder, C. (2011), The desire for shared decision making among patients with solid and hematological cancer. Psycho-Oncology, 20: 186–193. doi: 10.1002/pon.1723
- Issue published online: 17 MAR 2010
- Article first published online: 17 MAR 2010
- Manuscript Accepted: 4 JAN 2010
- Manuscript Revised: 15 DEC 2009
- Manuscript Received: 27 MAY 2009
- shared decision making;
Goal: The desire for shared decision making arises especially for frequently occurring cases of solid cancer. For hematological cancer conditions, there are no analogous results. This study compares the participation patients' desires concerning medical decisions dealing with their solid and hematological tumors.
Patients and Methods: The 533 inpatients with solid cancer (age<65: 61.0%; female: 39.6 %) and 177 patients with hematological cancer (inpatient: 62.1%, outpatient: 37.9%; age<65: 63.3%; female: 42.4%) were given a questionnaire after admission to a hospital or medical practice. The dependent variable was patient preference for control in decision making for eight different medical areas of decision.
Results: Descriptive results showed that patients with solid cancer had a stronger desire to participate in the decisions in six of a total of eight survey fields (p<0.01). When considering medical and socio-demographic control variables, the multivariate regression shows that the differences between the patient groups remain in all areas (p<0.01). Further predictor variables are educational background and age (p<0.05). No influence resulted from the factors of gender, medical or treatment characteristics.
Conclusion: The results show differences between patients with hematological cancer and patients with solid tumors, and these differences concern the preference to participate in medical decisions. Hemato–oncological patients desire less active participation and prefer a more dominant role of the physician in the various areas requiring decisions. Physicians should respect this in the course of the treatment. Copyright © 2010 John Wiley & Sons, Ltd.